GRI Bio, Inc. (GRI) stock
GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.27−0.08 (-5.95%)
Close on Nov 18, 2026Market cap $2.78MP/E –Yield –
GRI Bio profit margin
Profit margin (net margin) is net income as a percentage of revenue.
GRI Bio's profit margin for the twelve months ending Dec 31, 2020 was -4822.0%. For fiscal 2020 it was -4822.0%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -4822.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -1161.0% | – |
See a number that looks wrong?